Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 11, 2012, Pages 3965-3973

  Fischer, Evelyn ^a   Hanslik, Gregor ^b   Pallauf, Anna ^a   Degenhart, Christoph ^a   Linsenmaier, Ulrich ^a   Beuschlein, Felix ^a   Bidlingmaier, Martin ^a   Mussack, Thomas ^a   Ladurner, Roland ^a   Hallfeldt, Klaus ^a   Quinkler, Marcus ^b   Reincke, Martin ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; FLUDROCORTISONE; MINERALOCORTICOID; MINERALOCORTICOID ANTAGONIST; POTASSIUM; SPIRONOLACTONE;

ADRENAL CORTEX INSUFFICIENCY; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CREATININE BLOOD LEVEL; DISEASE DURATION; DISEASE PREDISPOSITION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; HORMONE SUBSTITUTION; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOALDOSTERONISM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POSTOPERATIVE COMPLICATION; POTASSIUM BLOOD LEVEL; PREDICTION; PREOPERATIVE EVALUATION; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; ZONA GLOMERULOSA;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENALECTOMY; ADULT; AGED; BLOOD PRESSURE; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERKALEMIA; KIDNEY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ZONA GLOMERULOSA;

EID: 84868626640     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-2234     Document Type: Article

References (40)

1. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young Jr WF 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-1050 (Pubitemid 38368386)
2. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young Jr WF, Montori VM 2008 Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266-3281
3. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-1248 (Pubitemid 40523144)
4. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA 2008 Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 168:80-85
5. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M 2009 Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab 94:1125-1130
6. Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA 2007 Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 50:911-918 (Pubitemid 350287534)
7. Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G 2005 Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 71:864-869
8. Meyer A, Brabant G, Behrend M 2005 Long-term follow-up after adrenalectomy for primary aldosteronism. World J Surg 29:155-159 (Pubitemid 40576461)
9. Sawka AM, Young WF, Thompson GB, Grant CS, Farley DR, Leibson C, van Heerden JA 2001 Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 135:258-261 (Pubitemid 32799339)
10. Letavernier E, Peyrard S, Amar L, Zinzindohoué F, Fiquet B, Plouin PF 2008 Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 26:1816-1823
11. Taniguchi R, Koshiyama H, Yamauchi M, Tanaka S, Inoue D, Sato Y, Sugawa A, Muramatsu Y, Sasano H 1998 A case of aldosterone-producing adenoma with severe postoperative hyperkalemia. Tohoku J Exp Med 186:215-223 (Pubitemid 29146857)
12. Huang WT, Chau T, Wu ST, Lin SH 2010 Prolonged hyperkalemia following unilateral adrenalectomy for primary hyperaldosteronism. Clin Nephrol 73:392-397
13. Gadallah MF, Kayyas Y, Boules F 1998 Reversible suppression of the renin-aldosterone axis after unilateral adrenalectomy for adrenal adenoma. Am J Kidney Dis 32:160-163 (Pubitemid 28311885)
14. Fischer E, Beuschlein F, Bidlingmaier M, Reincke M 2011 Commentary on The Endocrine Society Practice Guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism. Rev Endocr Metab Disord 12:43-48
15. Schirpenbach C, Segmiller F, Diederich S, Hahner S, Lorenz R, Rump LC, Seufert J, Quinkler M, Bidlingmaier M, Beuschlein F, Endres S, Reincke M 2009 The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. Dtsch Arztebl Int 106:305-311
16. Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S 2009 Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 94:869-875
17. Betz MJ, Degenhart C, Fischer E, Pallauf A, Brand V, Linsenmaier U, Beuschlein F, Bidlingmaier M, Reincke M 2011 Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur J Endocrinol 165:301-306
18. Vonend O, Ockenfels N, Gao X, Allolio B, Lang K, Mai K, Quack I, Saleh A, Degenhart C, Seufert J, Seiler L, Beuschlein F, Quinkler M, Podrabsky P, Bidlingmaier M, Lorenz R, Reincke M, Rump LC 2011 Adrenal venous sampling: evaluation of the German Conn's Registry. Hypertension 57:990-995
19. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA 2004 Role for adrenal venous sampling in primary aldosteronism. Surgery 136:1227-1235 (Pubitemid 39647538)
20. Choi MJ, Ziyadeh FN 2008 The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol 19:424-426 (Pubitemid 351355384)
21. Kreissler JJ, Langston CE 2011 A case of hyporeninemic hypoaldosteronism in the dog. J Vet Intern Med 25:944-948
22. Kamel KS, Ethier JH, Richardson RM, Bear RA, Halperin ML 1990 Urine electrolytes and osmolality: when and how to use them. Am J Nephrol 10:89-102
23. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F 2006 Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48:232-238 (Pubitemid 44309817)
24. Halimi JM, Mimran A 1995 Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 13:1801-1802 (Pubitemid 26015820)
25. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C 2006 Long-term renal outcomes in patients with primary aldosteronism. JAMA 295:2638-2645 (Pubitemid 43882339)
26. Quinkler M, Zehnder D, Eardley KS, Lepenies J, Howie AJ, Hughes SV, Cockwell P, Hewison M, Stewart PM 2005 Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation 112:1435-1443 (Pubitemid 41291769)
27. Lam EY, Funder JW, Nikolic-Paterson DJ, Fuller PJ, Young MJ 2006 Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats. Endocrinology 147:3623-3629 (Pubitemid 43901155)
28. Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, Chu TS, Huang KH, Wang SM, Lin YH, Chiang CK, Chang HW, Lin CY, Lin LY, Chiu JS, Hu FC, Chueh SC, Ho YL, Liu KL, Lin SL, Yen RF, Wu KD 2011 Kidney impairment in primary aldosteronism. Clin Chim Acta 412:1319-1325
29. Fourkiotis VG, Hanslik G, Hanusch F, Lepenies J, Quinkler M 2012 Aldosterone and the kidney. Horm Metab Res 44:194-201
30. Briet M, Schiffrin EL 2010 Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol 6:261-273
31. Ribstein J, Du Cailar G, Fesler P, Mimran A 2005 Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol 16:1320-1325 (Pubitemid 41716516)
32. Lafrance JP, Miller DR 2012 Dispensed selective and nonselective nonsteroidal anti-inflammatory drugs and the risk of moderate to severe hyperkalemia: a nested case-control study. Am J Kidney Dis 60:82-89
33. Mattsson C, Young Jr WF 2006 Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2:198-208; quiz, 1 p following 230
34. Bravo EL, Dustan HP, Tarazi RC 1975 Selective hypoaldosteronism despite prolonged pre- and postoperative hyperreninemia in primary aldosteronism. J Clin Endocrinol Metab 41:611-617
35. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T 2002 Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 51:350-355 (Pubitemid 34232637)
36. Fischer E, Beuschlein F, Degenhart C, Jung P, Bidlingmaier M, Reincke M 2012 Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry. Clin Endocrinol (Oxf) 76:473-477
37. Armanini D, Fiore C, Pellati D 2007 Spontaneous resolution of idiopathic aldosteronism after long-term treatment with potassium canrenoate. Hypertension 50:e69-e70 (Pubitemid 47442748)
38. Yoneda T, Demura M, Takata H, Kometani M, Karashima S, Yamagishi M, Takeda Y 2012 Unilateral primary aldosteronism with spontaneous remission after long-term spironolactone therapy. J Clin Endocrinol Metab 97:1109-1113
39. Conn JW, Hinerman DL 1977 Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies. Metabolism 26:1293-1307 (Pubitemid 8243284)
40. Sundsfjord JA, Marton P, Jorgensen H, Aakvaag A 1974 Reduced aldosterone secretion during spironolactone treatment in primary aldosteronism: report of a case. J Clin Endocrinol Metab 39:734-739